Stock Analysts

Q2 Gross Sales, EPS Dead-On With Our Estimates (PTX)

Brian Marckx, CFA Q2 Gross Sales, EPS Dead-On With Our Estimates Pernix Therapeutics ( PTX ) reported financial results for the second quarter on August 16th. While gross product sales came in almost dead-on with our estimate, net sales were well ahead as a result of relatively strong collaboration revenue and lower than expected Medicaid rebates. Despite the better net sales number, EPS of $0.07 was right where we had it modeled as a result of lower than estimated product margin and higher operating expenses. […]

Stock Analysts

Petrobras Tops Estimates, Profit Up (PBR) (PTR) (RDS.A) (XOM)

Brazilian state-run energy giant Petroleo Brasileiro S.A. ( PBR ) , or Petrobras S.A., announced its second quarter earnings of R$10.9 billion or R$0.84 per share, compared with R$8.3 billion or R$0.95 per share in the year-earlier quarter. Per share profitability dropped after the company sold $70 billion of new stock in September last year […]

Stock Analysts

Covidien Announces $2B Buyback (BCR) (BDX) (COV) (JNJ)

Leading healthcare products maker Covidien plc ( COV ) recently announced that its Board has authorized a share buyback program allowing it to repurchase up to $2 billion of its ordinary shares. The buyback will be executed from time to time, based on market conditions. The move underscores the Ireland-based company’s commitment to deliver incremental returns to investors leveraging a solid free cash flow and strong earnings power […]

Stock Analysts

Arrow Expands in Japan (ARW)

Arrow Electronics, Inc. ( ARW ) recently announced that it will launch a tender offer to acquire all of the common stock of Chip One Stop for ¥220,000 per share or $2,857 per share. Based in Japan, Chip One Stop supplies electronic components to design engineers. […]